The heterogeneity of estrogen receptor (ER) expression in metastatic breast cancer is measured by [18F]-fluoroestradiol (FES) PET.

被引：0
|
作者：
Mankoff, DA [1 ]
Tewson, TJ [1 ]
Peterson, LM [1 ]
Stekhova, S [1 ]
Gralow, JR [1 ]
Livingston, RB [1 ]
Moe, RE [1 ]
机构：
[1] Univ Washington, Med Ctr, Seattle, WA 98195 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2000年 / 41卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
108
引用
收藏
页码：28P / 28P
页数：1
相关论文
共 50 条
  • [1] Factors affecting the level and heterogeneity of uptake of [18F]fluoroestradiol (FES) in patients with estrogen receptor positive (ER+) breast cancer.
    Mankoff, DA
    Peterson, LM
    Petra, PH
    Stekhova, SA
    Link, JM
    Gralow, JR
    Livingston, RB
    Schubert, EK
    Tewson, TJ
    Krohn, KA
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 286P - 286P
  • [2] [18F]-fluoroestradiol (FES) Brain PET in the Evaluation of Patients with Estrogen Receptor Positive Breast Cancer Brain Metastases
    Sharbatdaran, Arman
    Osborne, Joseph
    Agee, Matthew
    Magge, Rajiv
    Jonathan, Knisely
    Schwartz, Theodore
    Pannullo, Susan
    Brandmaier, Andrew
    Andreopoulou, Eleni
    Ramakrishna, Rohan
    Ivanidze, Jana
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [3] Clinical production, stability studies and PET imaging with 16α-[18F] fluoroestradiol([18F]FES) in ER positive breast cancer patients
    Kumar, Piyush
    Mercer, John
    Doerkson, Courtney
    Tonkin, Katia
    McEwan, Alexander J. B.
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2007, 10 (02): : 256 - 265
  • [4] [18F]-Fluoroestradiol (FES) brain PET in the evaluation of patients with estrogen receptor positive breast cancer and known or suspected brain metastases
    Ivanidze, Jana
    Sharbatdaran, Arman
    McCalla, Aliah
    Brandmaier, Andrew
    Andreopoulou, Eleni
    Cristofanilli, Massimo
    Cigler, Tessa
    Balogun, Onyinye D.
    Magge, Rajiv S.
    Liechty, Benjamin
    Karakatsanis, Nicolas A.
    Nehmeh, Sadek A.
    Agee, Matthew A.
    Jean, Jolie
    Osborne, Joseph R.
    Beal, Kathryn
    Schwartz, Theodore H.
    Pannullo, Susan C.
    Knisely, Jonathan P. S.
    Ramakrishna, Rohan
    EUROPEAN JOURNAL OF RADIOLOGY, 2024, 181
  • [5] Temporal Heterogeneity of Estrogen Receptor Expression in Bone-Dominant Breast Cancer: 18F-Fluoroestradiol PET Imaging Shows Return of ER Expression
    Currin, Erin
    Peterson, Lanell M.
    Schubert, Erin K.
    Link, Jeanne M.
    Krohn, Kenneth A.
    Livingston, Robert B.
    Mankoff, David A.
    Linden, Hannah M.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (02): : 144 - 147
  • [6] Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol
    Peterson, Lanell M.
    Mankoff, David A.
    Lawton, Thomas
    Yagle, Kevin
    Schubert, Erin K.
    Stekhova, Svetlana
    Gown, Allen
    Link, Jeanne M.
    Tewson, Timothy
    Krohn, Kenneth A.
    JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (03) : 367 - 374
  • [7] Kinetic modeling of [18F]FES PET in patients with metastatic ER plus breast cancer
    Iqbal, Ramsha
    van Oordt, Catharina Menke-van der Houven
    Oprea-Lager, Daniela
    Schuit, Robert
    Windhorst, Albert
    Boellaard, Ronald
    Yaqub, Mohammed
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [8] [18F] fluoroestradiol (FES) PET as a predictive measure for endocrine therapy in women with newly diagnosed metastatic breast cancer
    Linden, Hannah
    Clark, Amy
    Fowler, Amy
    Novakova, Alena
    Mankoff, David
    Dehdashti, Farrokh
    CANCER RESEARCH, 2018, 78 (04)
  • [9] Negative estrogen receptor expression assessed by 18F-FES PET in metastatic breast cancer with ER-positive primary tumor
    Wang, Biyun
    You, Shuhui
    Xie, Yizhao
    Ji, Mengjing
    Yang, Zhongyi
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Predictive value of (16 alpha[18-F]-fluoroestradiol) FES-PET in recurrent estrogen receptor positive (ER plus ) breast cancer
    Roy, Felix-Nicolas
    Croteau, Etienne
    Ouellet, Rene
    Bujold, Rachel
    Forget, Andre
    Dufresne, Jean
    van Lier, Johannes
    Benard, Francois
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
12345